结缔组织病对美容手术后并发症的影响:一项匹配队列研究
结缔组织病组与对照组总并发症、主要并发症、次要并发症均无显著差异;但接受隆乳术的结缔组织病患者并发症显著多于匹配对照(双变量分析7例 vs 0例,P=0.018;多变量logistic回归OR 10.2,95%CI 1.21–93.3,P=0.039)。作者结论为多数美容手术可安全用于结缔组织病患者,隆乳术者应被告知术后并发症风险可能增加。
要点
- 结缔组织病组与对照组总并发症(69例 vs 60例)、主要并发症(23例 vs 16例)、次要并发症(46例 vs 44例)均无显著差异。
- 隆乳术结缔组织病患者并发症显著多于匹配对照(7例 vs 0例,P=0.018),多变量分析OR 10.2(95%CI 1.21–93.3,P=0.039)。
- 作者认为多数美容手术可安全用于结缔组织病患者,隆乳术者应被告知术后并发症风险可能增加。
核心结论
- 作者结论为多数美容手术可安全用于结缔组织病患者,寻求隆乳术者应被告知术后并发症风险可能增加。
研究设计与样本
- 回顾性匹配队列研究,纳入2003—2022年在本机构接受美容手术并经诊断的类风湿关节炎、系统性红斑狼疮和硬皮病患者,按种族、性别、体重指数、吸烟状态和合并症计算的倾向评分1:1匹配非结缔组织病对照。
主要发现
- 结缔组织病组与对照组总并发症分别为69例与60例(P=0.38),主要并发症分别为23例与16例(P=0.25),次要并发症分别为46例与44例(P=0.73),均无显著差异。
- 结缔组织病患者与对照在眼睑成形术(P=0.38)、乳房缩小术(P=0.91)、腹壁成形术(P=0.46)和除皱术(P=0.50)后的并发症均无显著差异。
- 接受隆乳术的结缔组织病患者并发症显著多于匹配的非结缔组织病对照,双变量分析为7例 vs 0例(P=0.018),多变量logistic回归OR为10.2(95%CI 1.21–93.3,P=0.039)。
临床怎么用
- 作者认为多数美容手术可安全用于结缔组织病患者,寻求隆乳术者应被告知术后并发症风险可能增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association between connective tissue diseases (CTDs), including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and scleroderma, and complications following aesthetic surgery is under-investigated. We hypothesized that the risk of complications following aesthetic surgery was higher in patients with these connective tissue disorders compared to matched non-CTD patients. METHODS: All patients diagnosed with RA, SLE, and scleroderma who underwent aesthetic surgery at our institution from 2003-2022 were reviewed. Demographic data, comorbidities, medications, procedures, and postoperative complications were collected. Non-CTD controls were identified for each procedure and matched 1:1 based on propensity scores derived from race, sex, body mass index, smoking status, and comorbidities. RESULTS: Six hundred 38 patients were included, comprising 319 (50%) patients diagnosed with CTD and 319 (50%) controls. The average age at surgery was 56.3 years. There were 129 complications. There were no differences between the CTD and non-CTD patients in number of total complications (69 versus 60, p = 0.38), major complications (23 versus 16, p = 0.25), or minor complications (46 versus 44, p = 0.73). Complications were not significantly different between CTD patients and controls who underwent blepharoplasty (p = 0.38), breast reduction (p = 0.91), abdominoplasty (p = 0.46), or rhytidectomy (p = 0.50). CTD patients who underwent breast augmentation had significantly more complications than matched non-CTD patients in bivariate analysis (7 versus 0, p = 0.018*) and multivariable logistic regression (OR: 10.2, 95% CI: 1.21 to 93.3, p = 0.039*). CONCLUSIONS: Most aesthetic surgeries can safely be performed in patients with CTDs. Patients seeking breast augmentation should be counseled on a potentially increased risk of postoperative complications.
引用
- Abbas F, Khalaf R, Reyes J, et al. Impact of connective tissue diseases on complications following aesthetic surgery: A matched cohort study. J Plast Reconstr Aesthet Surg. 2024. PMID: 39353284. doi:10.1016/j.bjps.2024.09.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。